Connections between obesity and dyslipidaemia

Area of Science:

• Cardiology
• Metabolic Disorders
• Obesity Research

Background:

• Historically, obesity's role in coronary heart disease (CHD) has been underestimated, viewed as a modifier rather than an independent risk factor.
• Medical practice often targets factors modified by obesity (e.g., high-density lipoprotein, blood pressure) instead of addressing excess weight itself.
• This reductionist approach has limited the focus on weight management in cardiovascular health.

Purpose of the Study:

• To re-evaluate the significance of obesity as an independent risk factor for coronary heart disease.
• To highlight the need for direct weight management strategies in patients with lipid disorders.
• To emphasize the implications of recognizing metabolic syndrome for clinical practice.

Main Methods:

• Review of existing scientific literature and clinical guidelines on obesity, lipid disorders, and coronary heart disease.
• Analysis of the impact of reductionist scientific views on therapeutic approaches.
• Examination of the potential influence of the Adult Treatment Panel III (ATP III) definition of metabolic syndrome.

Main Results:

• Excess body weight is increasingly recognized as an independent risk factor for CHD.
• Current therapeutic strategies often indirectly address obesity by managing its consequences.
• The identification of metabolic syndrome provides a framework to reconsider obesity's central role.

Conclusions:

• A paradigm shift is needed to view obesity as a primary target for CHD prevention.
• Weight management should be a cornerstone therapy for patients with lipid disorders and metabolic syndrome.
• Clinical guidelines and practice should prioritize addressing excess body weight to mitigate cardiovascular risk.